AstraZeneca gets EU nod to diabetes drug Forxiga Medical Dialogues Bureau27 March 2019 9:25 AM GMTFarxiga or Forxiga, as the drug is known outside the United States, is one of AstraZeneca's top ten drugs by sales. It generated $1.39 billion in 2018...
Relief to Lupin: High court removes ban its diabetes drug Gluconorm P 30 Meghna A Singhania23 Feb 2019 7:27 AM GMTThe high court has now ruled in favour of Lupin and quashed the apex court's decision to ban Lupin's anti-diabetic drug- Gluconorm P 30.New Delhi: In...
Novo Nordisk wins EU panel's backing for key diabetes drug Ruby Khatun Khatun18 Dec 2017 5:00 AM GMTCOPENHAGEN: Danish drugmaker Novo Nordisk came closer to winning European approval for diabetes drug Ozempic, it's biggest growth prospect when a...
Novo Nordisk settles US probe over diabetes drug for nearly 58.7 million dollar Ruby Khatun Khatun7 Sep 2017 5:18 AM GMTNovo Nordisk will pay nearly $58.7 million to resolve claims the drugmaker's sales staff downplayed the importance of U.S. Food and Drug...